znt8 type 2 diabetes
Loss-of-function mutations protective against human disease provide in vivo validation of therapeutic targets 1, 2, 3, but none have yet been described for type 2. The zinc transporter 8 (znt8) action group: the znt8 in type 1 and type 2 diabetes etiology and pathogenesis. The diabetes-susceptible gene slc30a8/znt8 regulates hepatic to type 2 diabetes. precise role of znt8 in increased susceptibility to type 2.
Znt8 burst onto the scene in 2007 as a promising diabetes target, and follow-up studies suggested that stimulating the zinc transporter protein could have therapeutic. 1. genet mol res. 2012 may 24;11(2):1592-8. doi: 10.4238/2012.may.24.1. slc30a8 (znt8) variations and type 2 diabetes in the chinese han population.. Eiji kawasaki 1) 1) department of metabolism/diabetes and clinical nutrition, nagasaki university hospital, nagasaki 852-8501, japan.
0 komentar:
Posting Komentar